SEOUL -- Samsung Biologics looks to develop a treatment for Alzheimer's disease in partnership with Taiwanese startup Aprinoia Therapeutics, as the South Korean manufacturer moves further up the value chain to attract new clients.
Pharmaceuticals
Alzheimer's trials: Samsung biotech arm joins Taiwan startup
South Korean company seeks to move further up the value chain
Samsung Biologics, a leading South Korean company by market capitalization, plans to build a research center in California as it expands beyond contract manufacturing. (Photo courtesy of Samsung Biologics)
Read Next
Latest on Pharmaceuticals
